These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2004-004567-29 Pelvic lymph node metastases from bladder and prostate cancer magnetic resonance imaging with ultrasmall superparamagnetic iron oxyde sinerem. bad-data
Completed, but no date Terminated 2005-005274-71 SPONTANEOUS STUDY WITH ADJUVANT TRASTUZUMAB HERCEPTIN IN WOMEN WITH HER-2 POSITIVE PRIMARY BREAST CANCER WHO HAVE COMPLETED ADJUVANT CHEMOTHERAPY bad-data
Ongoing 2006-000231-95 A PHASE II STUDY OF BAY 43-9006 IN COMBINATION WITH WEEKLY GEMCITABINE FOR THE TREATMENT OF METASTATIC RCC EITHER UNSUITABLE FOR OR REFRACTORY TO PRIOR TREATMENT WITH CYTOKINES not-yet-due
Ongoing 2006-001779-39 Phase II trial FOLFOX combined with Bevacizumab, Cetuximab and Imatinib in patients with advanced untreated colorectal cancer not-yet-due
Completed, but no date 2006-006669-17 PILOT STUDY OF OXCARBAZEPINE TOLEP ACTIVITY IN ANTICANCER DRUGS NEUROPHATIES bad-data
Not reported 2006-006808-11 Phase II study of 90Y ibritumomab tiuxetan (Zevalin) in patients with untreated follicular non-Hodgkin's lymphoma. 2016-02-15 due-trials
Not reported 2007-003692-39 Evaluation of immunogenicity of 7-valent Pneumococcal Conjugate Vaccine (Prevenar) and Hexavalent DtPa-HBV-IPV-Hib (InfaNrix Hexa), co-administered at the same time, versus Hexavalent vaccine, used i... 2008-05-30 due-trials
Ongoing 2007-003896-38 PHARMACOKINETICS AND PHARMACODYNAMICS IN THE OPTIMIZATION OF ANTIRETROVIRAL TREATMENT. not-yet-due
Ongoing 2007-004010-14 PILOT STUDY ON THE ACTIVITY OF TROPISETRON IN myofascial and neuropathic pain not-yet-due
Not reported Terminated 2007-006060-29 Efficacy and toxicity of Trastuzumab at the maintaining dose of 1 mg/kg/week versus the standard dose of 2 mg/kg/week in combination with chemotherapy in metastatic breast cancer patients. A phase III... 2011-12-21 due-trials
Ongoing 2008-000570-21 Randomized phase II study of adjuvant chemotherapy with cisplatin + vinorelbine vs gemcitabine + vinorelbine in stage IB-IIIA radically resected non-small cell lung cancer (NSCLC) patients not-yet-due
Ongoing 2009-010786-22 Open label, phase III, multicentric randomised trial, comparing five years of treatment with a non steroidal aromatase inhibitor, either anastrozole or letrozole, versus switching after 2-3 years to t... not-yet-due
Completed, but no date 2009-014637-24 On field immunization with a novel influenza vaccine administered via intradermic route (Intanza): tolerability, safety, immunogenicity and acceptability study in subjects ≥ 60 years and evaluation of... bad-data
Ongoing 2010-019977-14 Efficacy of Cilostazol for the treatment of Raynaud’s Phenomenon in patients affected by Systemic Sclerosis not-yet-due
Ongoing 2010-021600-24 FEC neo-adjuvant chemotherapy followed by weekly Taxol administration combined with Trastuzumab in II-III stage HER2 positive breast cancer patients.Fase II trial. not-yet-due
Ongoing 2011-005267-24 A multi-center phase II randomized study of CustOmized Neoadjuvant ThErapy vs Standard chemoTherapy in non-small cell lung cancer (NSCLC) patients with resectable stage IIIA (N2) disease (CONTEST tria... not-yet-due
Ongoing 2013-001330-17 Comparison between diagnostic accuracy of [11C]-choline PET/CT and conventional imaging in prostate cancer patients Confronto tra l’accuratezza diagnostica della [11C]-colina e dell’imaging conven... not-yet-due
Ongoing 2013-001629-23 A phase III study comparing the concurrent versus the sequential administration of chemotherapy and aromatase inhibitors, as adjuvant treatment of post-menopausal patients with endocrine-responsive ea... not-yet-due
Reported results 2016-001034-10 Neurophysiological assessment of the effect of Sativex (THC/CBD oromucosal spray) as add-on to treat spasticity following stroke Valutazione neurofisiologica dell'effetto del Sativex (THC/CBD Spray... 2020-02-20 due-trials
Other 2020-001588-10 A randomized, phase IIb study of adjuvant durvalumab (MEDI4736) plus regorafenib vs untreated control in stage IV colorectal cancer patients with no evidence of disease (NED): VIVA trial Studio r... not-yet-due
Ongoing 2020-004270-22 PHASE II STUDY OF TOTAL MARROW AND LYMPHOID IRRADIATION (TMLI) GIVEN IN COMBINATION WITH CYCLOPHOSPHAMIDE AND ETOPOSIDE (VP-16) AS CONDITIONING FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (... not-yet-due
Completed, report not yet due 2020-004835-26 Single-center, randomized, controlled study to evaluate the effects of a six-month treatment with renal glucose transport inhibitor (SGLT2i) drugs on markers of senescence, inflammation and tubulointe... 2024-10-31 not-yet-due
Ongoing 2021-003275-34 TEMOZOLOMIDE + ULTRA-HYPER-FRACTIONATED RADIOTHERAPY VS TEMOZOLOMIDE ALONE FOR THE MAINTENANCE TREATMENT OF GLIOBLASTOMA PATIENTS - PILOT STUDY Temozolomide + radioterapia ultra-iper-frazionata ris... not-yet-due